Alantos Pharmaceuticals

About:

Alantos Pharmaceuticals is a dynamic international biopharmaceutical company focused on developing small molecule pharmaceuticals.

Website: http://www.alantos.com/

Top Investors: Earlybird Venture Capital, SV Health Investors, Ventech, Oxford Bioscience Partners, ABN AMRO Fund

Description:

Alantos Pharmaceuticals is a chemistry-driven biopharmaceutical company. It engages in the discovery and development of small molecule drugs for osteoarthritis, inflammation, and type II diabetes. Their products include Dipeptidyl and Peptidase IV inhibitor. The company offers various tissue remodeling pathways for rheumatoid arthritis, liver fibrosis, cardiovascular, chronic wound healing, and cancer. Alantos Pharmaceuticals was founded in 2002 and is based in Cambridge, Massachusetts.